AbbVie (ABBV) Earnings Date, Estimates & Call Transcripts $172.78 +1.10 (+0.64%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$173.96 +1.18 (+0.68%) As of 04/17/2025 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AbbVie Earnings Summary Upcoming Earnings DateApr. 25Before Market OpensEstimatedConsensus EPS (Jan. 31) $2.98 Actual EPS (Jan. 31) $2.16 Missed By -$0.82 AbbVie posted Q4 2024 earnings on January 31, 2025, reporting an EPS of $2.16, which missed analysts' consensus estimates of $2.98 by $0.82. With a trailing EPS of $2.40 and a P/E Ratio of 71.99, AbbVie's earnings are expected to grow 13.57% next year, from $12.31 to $13.98 per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Annual Report (10-K) Press Release (8-K)ABBV Upcoming EarningsAbbVie's Q1 2025 earnings is scheduled for Friday, April 25, 2025, with a conference call scheduled at 9:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get AbbVie Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AbbVie and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataABBV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABBV Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. AbbVie Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20253$2.38$2.50$2.432.340 - 2.380Q2 20253$3.05$3.37$3.16 Q3 20253$3.02$3.23$3.15 Q4 20253$3.27$3.43$3.36 FY 202512$11.72$12.53$12.11 Q1 20261$2.88$2.88$2.88 Q2 20261$3.33$3.33$3.33 Q3 20261$3.63$3.63$3.63 Q4 20261$3.80$3.80$3.80 FY 20264$13.64$13.64 $13.64 AbbVie Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 4/25/2025(Estimated)-------1/31/2025Q4 2024$2.98$2.16 -$0.82-$0.02$14.81B-10/30/2024Q3 2024$2.92$3.00+$0.08$5.12$14.28B$14.46B7/25/2024Q2 2024$2.57$2.65+$0.08$4.53$14.02B$14.46B5/3/2024Q1 2024$2.26$2.31+$0.05$3.85$11.93B$12.31B2/2/2024Q4 2023$2.76$2.79+$0.03$5.12$14.02B$14.30B10/27/2023Q3 2023$2.86$2.95+$0.09$4.90$13.72B$13.93B7/27/2023Q2 2023$2.79$2.91+$0.12$4.68$13.52B$13.87B4/27/2023Q1 2023$2.44$2.46+$0.02$4.79$12.23B$12.23B AbbVie Earnings - Frequently Asked Questions When is AbbVie's earnings date? AbbVie has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, April 25th, 2025 based off last year's report dates. Learn more on ABBV's earnings history. What guidance has AbbVie issued on next quarter's earnings? AbbVie updated its FY 2025 earnings guidance on Friday, April, 4th. The company provided earnings per share guidance of 11.990-12.190 for the period, compared to the consensus earnings per share estimate of 12.280. The company issued revenue guidance of -. Did AbbVie beat their earnings estimates last quarter? In the previous quarter, AbbVie (NYSE:ABBV) missed the analysts' consensus estimate of $2.98 by $0.82 with a reported earnings per share (EPS) of $2.16. Learn more on analysts' earnings estimate vs. ABBV's actual earnings. How can I listen to AbbVie's earnings conference call? The conference call for AbbVie's latest earnings report can be listened to online. Listen to Conference Call How can I read AbbVie's conference call transcript? The conference call transcript for AbbVie's latest earnings report can be read online. Read Transcript How much revenue does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded annual revenue of $56.33 billion. How much profit does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded net income of $4.28 billion. ABBV has generated $2.40 earnings per share over the last four quarters. What is AbbVie's price-to-earnings ratio? AbbVie (NYSE:ABBV) has a trailing price-to-earnings ratio of 71.99 and a forward price-to-earnings ratio of 14.04. The price/earnings-to-growth ratio is 1.62. What is AbbVie's EPS forecast for next year? AbbVie's earnings are expected to grow from $12.31 per share to $13.98 per share in the next year, which is a 13.57% increase. More Earnings Resources from MarketBeat Related Companies Eli Lilly and Company Earnings Results Johnson & Johnson Earnings Results Merck & Co., Inc. Earnings Results Pfizer Earnings Results Bristol-Myers Squibb Earnings Results Zoetis Earnings Results Royalty Pharma Earnings Results Corcept Therapeutics Earnings Results Jazz Pharmaceuticals Earnings Results Perrigo Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Aviation Unveils NYC Network Ahead of Key Earnings Report3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions Ahead This page (NYSE:ABBV) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
